MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway

Published:2022-04 Issue: Volume:33 Page:100412
ISSN:2212-1374
Container-title:Journal of Bone Oncology
language:en
Short-container-title:Journal of Bone Oncology

Author:

Cao Dong,Ge Shanshan,Li Mengchun

Publisher

Elsevier BV

Subject

Oncology

Reference37 articles.

1. Bone cancer: diagnosis and treatment principles;Ferguson;Am. Fam. Phys.,2018

2. Epidemiology and risk factors of osteosarcoma;Sadykova;Cancer Invest.,2020

3. Osteosarcoma: current treatment and a collaborative pathway to success;Isakoff;J Clin Oncol,2015

4. Update on survival in osteosarcoma;Anderson;Orthoped Clin N Am,2016

5. Metastatic osteosarcoma: a challenging multidisciplinary treatment;Meazza;Expert Rev. Anticancer Ther.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6;Biology Direct;2024-07-08

2. Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma;Cellular and Molecular Life Sciences;2024-06-28

3. Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases;Biomolecules;2024-04-24

4. The essential roles of m6A modification in osteogenesis and common bone diseases;Genes & Diseases;2024-01

5. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing;Cell Communication and Signaling;2023-12-15